loading

Finanzdaten der Aura Biosciences Inc-Aktie (AURA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
4.52%
23.34
22.33 17.04 16.88 17.05
Operating Income/Loss
4.42%
-29.04
-27.81 -23.23 -22.76 -22.31
Nonoperating Income/Loss
21.38%
1.57
1.997 2.233 2.425 2.653
Income/Loss From Continuing Operations Before Tax
6.41%
-27.46
-25.81 -21.00 -20.34 -19.66
Income Tax Expense/Benefit
25.00%
0.018
0.024 0.043 - 0.046
Income/Loss From Continuing Operations After Tax
6.38%
-27.48
-25.83 -21.04 -20.34 -19.71
Net Income/Loss
6.38%
-27.48
-25.83 -21.04 -20.34 -19.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
52,361%
50.13
0.0956 49.66 49.55 49.45
Diluted Average Shares
52,361%
50.13
0.0956 49.66 49.55 49.45
Basic Earnings Per Share
5.77%
-0.55
-0.52 -0.42 -0.41 -0.40
Diluted Earnings Per Share
5.77%
-0.55
-0.52 -0.42 -0.41 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):